Metabolites from Marine Microorganisms, Micro, and Macroalgae: Immense Scope for Pharmacology
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Marine organisms produce a large array of natural products with relevance in drug discovery. These compounds have biological activities such as antioxidant, antibacterial, antitumor, antivirus, anticoagulant, anti-inflammatory, antihypertensive, antidiabetic, and so forth. Consequently, several of the metabolites have made it to the advanced stages of clinical trials, and a few of them are commercially available. In this review, novel information on natural products isolated from marine microorganisms, microalgae, and macroalgae are presented. Given due research impetus, these marine metabolites might emerge as a new wave of promising drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Medicinal and pharmaceutical uses of seaweed natural products: A review
Smit, A. J. (2004) · Journal of Applied Phycology · doi:10.1023/b:japh.0000047783.36600.ef · Cited by 806
Applications of cyanobacteria in biotechnology
Abed, R. M. M., Dobretsov, S., & Sudesh, K. (2009) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2008.03918.x · Cited by 528 · cited 1×
“Many antifungal compounds have been isolated from marine extracts of cyanobacteria, including hapalindoles, tolytoxin (Figure 3A), 7-OMe-scytophycin-B, toyocamycin (Figure 3B), tjipanazole D (Figure 3G), hassallidin A, nostocyclamide, and nostodione A (Figure 3F) [56].”
BackgroundBlunt, J. W., Copp, B. R., Hu, W.-P., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2009) · Natural Product Reports · doi:10.1039/b805113p · Cited by 520
Innovative natural functional ingredients from microalgae
Plaza, M., Herrero, M., Cifuentes, A., & Ibáñez, E. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf901070g · Cited by 509 · cited 1×
“Significant biochemical differences have been found among marine microalgae, resulting in a broad spectrum of novel bioactive compounds [33] of pharmaceutical interest [34].”
BackgroundMarine Bioactive Compounds and Their Health Benefits: A Review
Hamed, I., Özogul, F., Özogul, Y., & Regenstein, J. M. (2015) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12136 · Cited by 444
Marine natural products and their potential applications as anti-infective agents
Donia, M., & Hamann, M. T. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00655-8 · Cited by 425 · cited 1×
“In the past decades, several promising therapeutics have been extracted from bacteria, fungi, corals, micro- and macroalgae, gorgonians, sponges, nudibranchs, bryozoans, sea cucumbers, tunicates, and sea hares, among other marine organisms [3].”
BackgroundTrimurtulu, G., Ohtani, I., Patterson, G. M. L., Moore, R. E., Corbett, T. H., Valeriote, F. A., & Demchik, L. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00090a020 · Cited by 303
Volk, R.-B., & Furkert, F. H. (2006) · Microbiological Research · doi:10.1016/j.micres.2005.08.005 · Cited by 247 · cited 1×
“Cyanobacteria (Cyanophyta) are a group of Gram-negative bacteria and one of the richest sources of novel bioactive compounds with antifungal, anti-inflammatory, antibiotic, and antitumor activities (Table 1), which make them interesting candidates for the production of molecules for new potential pharmaceutical applic…”
BackgroundHayashi, K., Nakano, T., Hashimoto, M., Kanekiyo, K., & Hayashi, T. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2007.10.017 · Cited by 247
Medina, R. A., Goeger, D. E., Hills, P., Mooberry, S. L., Huang, N., Romero, L. I., Ortega-Barría, E., Gerwick, W. H., & McPhail, K. L. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801383f · Cited by 231 · cited 3×
“4 μM; selectivity is conferred by the arginine residue Trypsin inhibitor Cyanobacterium/Lyngbya confervoides Pompanopeptin A Pantropical cyanobacteria/ Caldora penicillata Antitumor cytotoxicity Inhibits VEGFA/VEGFR2 expression and s pp esses tumor growth in gliobl s oma xenografts [27,28]”
BackgroundGanesan, P., Noda, K., Manabe, Y., Ohkubo, T., Tanaka, Y., Maoka, T., Sugawara, T., & Hirata, T. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.02.008 · Cited by 187
Moubayed, N. M. S., Al Houri, H. J., Al Khulaifi, M. M., & Al Farraj, D. A. (2017) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2016.05.018 · Cited by 145
Antimicrobial and Cytotoxic Assessment of Marine Cyanobacteria - Synechocystis and Synechococcus
Martins, R., Ramos, M., Herfindal, L., Sousa, J., Skærven, K., & Vasconcelos, V. (2008) · Marine Drugs · doi:10.3390/md6010001 · Cited by 117 · cited 1×
“showed significant antimicrobial activity towards Gram-positive bacteria [44].”
Background
Cited by
Ferreira, I., Falcato, F., Bandarra, N., & Rauter, A. P. (2022) · Molecules · doi:10.3390/molecules27051677 · Cited by 120
Natural antimicrobial agents from algae: current advances and future directions
Zuorro, A., Lavecchia, R., Contreras-Ropero, J. E., Martínez, J. B. G., Barajas-Ferreira, C., & Barajas-Solano, A. F. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111826 · Cited by 39
Metadata
- Authors
- Barzkar, N., Jahromi, S. T., Poorsaheli, H. B., & Vianello, F.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2019-08-08
- Volume
- 17
- Issue
- 8
- Pages
- 464
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W2968847299
- Cited by
- 178
- References
- 13
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.